Lewes, DE -- (SBWIRE) -- 10/29/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: VIVUS, Inc. (NASDAQ:VVUS), Cowen Group, Inc. (NASDAQ:COWN), Cumulus Media Inc (NASDAQ:CMLS), Galena Biopharma Inc (NASDAQ:GALE)
VIVUS, Inc. (NASDAQ:VVUS) opened its shares at the price of $9.34 for the day. Its closing price was $9.59 after gaining +2.13% for the day. The company traded with the total volume of 1.27 million shares, while its average trading volume remained 2.78 million shares. The beta of VVUS stands at1.33. VIVUS, Inc., a biopharmaceutical company, engages in developing and commercializing therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health.
Why Should Investors Buy VVUS After The Recent Gain? Just Go Here and Find Out
Cowen Group, Inc. (NASDAQ:COWN) percentage change surged +3.66% to close at $3.97 with the total traded volume of 1.25 million shares, and average volume of 664,091.00 shares. The 52 week range of the stock remained $2.16 - $4.03, while its day lowest price was $3.81 and it hit its day highest price at $4.03. Cowen Group, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides alternative investment management, investment banking.
Will COWN Continue To Move Higher? Find Out Here
Cumulus Media Inc (NASDAQ:CMLS) started its trading session with the price of $5.77 and closed at $5.74 by scoring -1.03%. CMLS’s stocks traded with total volume of 1.25 million shares, while the average trading volume 2.27 million shares. The beta of CMLS stands at 2.33. Day range of the stock was $5.65 -$5.85. Cumulus Media Inc. owns and operates commercial radio station clusters in the United States. The company engages in the sale of local, regional, and national advertising for broadcast on its radio stations.
Has CMLS Found The Bottom and Ready To Move Up? Find Out Here
Galena Biopharma Inc (NASDAQ:GALE) ended its day with the loss of -2.24% and closed at the price of $2.18 after opening at $2.22. Stock traded during its last trading session with the total volume of 1.25 million shares, as compared to its average volume of 3.10 million shares. Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing oncology treatments to address major unmet medical needs to advance cancer care.
Has GALE Found The Bottom And Ready To Gain Momentum? Find Out Here
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)